How peptides work: structure, receptors and signalling

A peptide is a short chain of amino acids, and what it does in an experiment comes down to two things: its structure and the system it is placed in. The same sequence can behave very differently in a buffer, in cultured cells and in a living animal. This article explains how structure shapes activity, how receptor signalling works in broad terms, and why a mechanism measured in the lab is a starting point rather than a conclusion. For the basics of what peptides are and how they are made, see what are research peptides.

Sequence decides shape

Every peptide is defined by its sequence, the order of its amino acids. Each residue brings its own size, charge and affinity for water, and together they decide how the chain folds. Some short peptides stay flexible; others form a helix or a turn, or are held in shape by a ring or a disulfide bond.

Small changes matter. Swapping one residue, adding a chemical group to either end or attaching a fatty-acid chain can change how tightly a peptide binds its target, how quickly enzymes break it down and how long it stays intact in a sample. That is why results for one peptide cannot simply be carried over to a similar one. Analogues such as retatrutide and tirzepatide were designed precisely because small structural edits change behaviour.

Receptors and signal transduction

Many peptides act by binding a receptor, a protein on or in a cell that recognises a particular shape. A large share of peptide receptors belong to the G protein-coupled receptor family, which spans the cell membrane.

When a peptide binds such a receptor, the receptor changes shape and passes a signal into the cell. That signal travels through a chain of molecules, often called a signalling cascade, and can end in a change in enzyme activity or gene expression. The whole process is called signal transduction.

Researchers describe binding with a few standard terms:

• Affinity: how strongly a peptide binds its target.
• Agonist: a molecule that binds and activates a receptor.
• Antagonist: a molecule that binds and blocks a receptor without activating it.
• Selectivity: how strongly a molecule prefers one target over others.

Not every peptide uses a receptor

Receptor binding is common, but it is not the only route. Some peptides interact with enzymes, some with cell membranes, and some bind metal ions or other molecules. The copper tripeptide GHK-Cu, for example, is studied largely for how it binds copper. These are broad patterns, not one mechanism shared by every peptide.

From assay to organism

A laboratory assay can measure binding, or a change in a signalling marker in cultured cells. That tests a specific hypothesis under controlled conditions, which is valuable. But an isolated assay leaves out most of what happens in a living system: absorption, distribution, breakdown, clearance and interactions with targets nobody measured.

So evidence is best read in layers:

• Biochemical studies can show that an interaction is possible.
• Cell studies explore what follows from it in a model.
• Animal studies test selected effects in a whole organism.
• Well-designed human studies are needed before anything can be said about outcomes in people.

Each layer answers a different question, and a result at one layer does not guarantee the next. Our guide to in vitro, in vivo and clinical research explains the differences in more detail.

Reading a mechanism claim

When an article or a product page describes how a peptide "works", ask:

• What exact target was measured, and in what system?
• What controls were used?
• Has the result been repeated by another group?
• Does the cited paper actually support the wording used?

A mechanism is a useful hypothesis. It is not evidence of an effect, and it is not evidence of safety. For a checklist on judging the study behind a claim, see how to evaluate peptide studies.

Common questions

Does receptor binding prove a peptide works?

No. Binding is one step in a proposed mechanism. It does not show that a meaningful effect follows in a cell, an animal or a person.

Can results for one peptide be applied to a similar one?

Not automatically. Small structural differences can change binding, stability and selectivity, so each molecule needs its own evidence.

Sources

• Wang L. et al. Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy, 2022
• Fosgerau K., Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today, 2015

Documented material for receptor research

Receptor work depends on knowing exactly which molecule is in the vial. Peptune publishes certificates of analysis on each product page as they arrive, and in the certificate library. Browse the full catalogue.

For laboratory research use only. Nothing in this article is medical advice or a suggestion to use any compound on people or animals.